Glenmark announces discovery of novel cancer drug

Glenmark Pharmaceuticals has announced the discovery of a new anti-cancer therapy by its Swiss subsidiary. The new drug, GBR 1302, will target breast cancer and ovarian cancer, and the company expects to start clinical studies this year. Unlike normal drugs, the new drug will work by making it easier for human body’s defence mechanism, white […]